Adaptive Phage Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Adaptive Phage Therapeutics's estimated annual revenue is currently $4.8M per year.
- Adaptive Phage Therapeutics received $41 in venture funding in May 2021.
- Adaptive Phage Therapeutics's estimated revenue per employee is $192,200
- Adaptive Phage Therapeutics's total funding is $94.7M.
Employee Data
- Adaptive Phage Therapeutics has 25 Employees.
- Adaptive Phage Therapeutics grew their employee count by -44% last year.
Adaptive Phage Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Project Management | Reveal Email/Phone |
3 | Director, Quality | Reveal Email/Phone |
4 | Director, Clinical Program Management | Reveal Email/Phone |
5 | Senior Director HR Business Partner | Reveal Email/Phone |
6 | Director, Product Development | Reveal Email/Phone |
7 | Associate Director, Quality | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Associate Director, HR & Administration | Reveal Email/Phone |
10 | Manager, Manufacturing Operations | Reveal Email/Phone |
Adaptive Phage Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 13 | 0% | N/A | N/A |
#8 | $7.4M | 47 | 21% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Adaptive Phage Therapeutics?
Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. Two key components of APT's approach are 1) PhageBank™, a large and dynamically growing collection of bacteriophages or “phages†(viruses that attack specific targeted bacteria) and 2) an innovative rapid system for matching phage to patient-specific bacterial infections. In 2016 APT's approach achieved its first in-human success with the rescue of a critically ill MDR infected patent.
keywords:N/A
$94.7M
Total Funding
25
Number of Employees
$4.8M
Revenue (est)
-44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Adaptive Phage Therapeutics News
Funding will be used to accelerate clinical trials against Prosthetic Joint Infection (PJI) and Diabetic Foot Osteomyelitis (DFO) -...
Adaptive Phage Therapeutics, Inc., a Gaithersburg, MD-based clinical-stage biotechnology company dedicated to providing therapies to treat...
Gaithersburg's Adaptive Phage Therapeutics Inc. has raised ... year after securing nearly $41 million to advance its therapy for superbugs.
Other Companies in Gaithersburg
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 25 | -37% | N/A |
#2 | $7.2M | 25 | 25% | N/A |
#3 | $5.8M | 26 | 4% | N/A |
#4 | N/A | 26 | 30% | N/A |
#5 | $3.7M | 26 | -7% | N/A |
Adaptive Phage Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2021-05-07 | $41 | B | Deerfield Management | Article |